Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization

European Journal of Radiology

Volumn 81, Issue 3, 2012, Pages 472-477

  Dong, Sheng ^a   Ye, Xiao Dan ^b   Yuan, Zheng ^a,c   Xu, Li Chao ^a   Xiao, Xiang Sheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI CHEST HOSPITAL   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

ADC; Chemoembolization; Diffusion weighted imaging; Hepatocellular carcinoma; Survival

Indexed keywords

CISPLATIN; EPIRUBICIN; IOPROMIDE; MITOMYCIN C;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 84856950266     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.12.081     Document Type: Article

References (26)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. D.Y. Lin, Y.F. Liaw, and T.Y. Lee Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: a randomized controlled trial Gastroenterology 94 1988 453 456
3. G. Pelletier, A Roche, and O. Ink A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 1990 181 184
4. J. Bruix, J.M. Llovet, and A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583
5. C.Y. Chen, C.W. Li, and Y.T. Kuo Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience Radiology 239 2006 448 456
6. I.R. Kamel, D.A. Bluemke, and J. Eng The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 2006 505 512
7. T.K. Rhee, N.K. Naik, and J. Deng Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging J Vasc Interv Radiol 19 2008 1180 1186
8. B.J. Youn, JW Chung, and K.R. Son Diffusion-weightedMR:therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver Acad Radiol 15 2008 593 600
9. I.R. Kamel, E. Liapi, and D.K. Reyes Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging Radiology 250 2009 466 473
10. Z. Yuan, X.D. Ye, and S. Dong Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma Eur J Radiol 75 2010 e9 e14
11. H. Lau, S.T. Fan, and I.O. Ng Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients Cancer 83 1998 2302 2311
12. R.T. Poon, I.O. Ng, and S.T. Fan Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort J Clin Oncol 19 2001 3037 3044
13. R.T. Poon, H. Ngan, and C.M. Lo Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence J Surg Oncol 73 2000 109 114
14. J.D. Wayne, G.Y. Lauwers, and I. Ikai Preoperative predictors of survival after resection of small hepatocellular carcinomas Ann Surg 235 2002 722 731
15. M. Lise, S. Bacchetti, and P. Da Pian Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients Cancer 82 1998 1028 1036
16. The Liver Cancer Study Group of Japan Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan Cancer 74 1994 2772 2780
17. M. Pompili, G.L. Rapaccini, and M. Covino Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy Cancer 92 2001 126 135
18. Y. Yamashita, M. Takahashi, and Y. Koga Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion Cancer 67 1991 385 391
19. H.X. Xu, M.D. Lu, and X.Y. Xie Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients Clin Radiol 60 2005 1018 1025
20. H. Kuriyama, S. Okada, and T. Okusaka Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection J Gastroenterol Hepatol 17 2002 1205 1210
21. T. Livraghi, F. Meloni, and A. Morabito Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center Liver Transpl 10 2004 S98 S106
22. K. Sako, Y. Komorizono, and M. Oketani Outcome of patients with hepatitis C virus-related single, small hepatocellular carcinoma Anticancer Res 23 2003 4191 4196
23. T. Livraghi, A. Giorgio, and G. Marin Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection Radiology 197 1995 101 108
24. D.M. Koh, E. Scurr, and D. Collins Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients AJR Am J Roentgenol 188 2007 1001 1008
25. L. Harrison, and K. Blackwell Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9 suppl 5 2004 31 40
26. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739